Navigation Links
Severe Bacterial Strain Found in Cystic Fibrosis Patients in Canada
Date:11/16/2010

TUESDAY, Nov. 16 (HealthDay News) -- Researchers have found that many cystic fibrosis (CF) patients in Canada have a common transmissible strain of the bacteria Pseudomonas aeruginosa, which can increase the risk of death or the need for a lung transplant.

It's not known if the strain, first identified in the U.K., is yet common among CF patients in the United States.

Researchers looked at 446 CF patients in Ontario and found that 102 of them were infected with one of two common strains. Sixty-seven were infected with strain A, 32 were infected with strain B, and three were infected with both strains.

The study appears in the Nov. 17 issue of the Journal of the American Medical Association.

According to background information in the study, the significant variation in the prognosis of patients with P aeruginosa may partly result from differences among infecting strains.

Strain A was genetically identical to the Liverpool (England) epidemic strain first identified in 1996, but strain B has not previously been regarded as an epidemic strain. The three-year risk of death or need for a lung transplant was twice as high in patients with strain A (18.6 percent) than in those with unique strains (8.7 percent). The risk for patients with strain B was similar to those with unique strains.

"The results of our study indicate that a sizable minority of adult Canadian patients with CF living in the province of Ontario are infected with 1 of 2 common strains of P aeruginosa. The most prevalent transmissible strain found was the Liverpool epidemic strain, which was found to infect more than 15 percent of Ontario patients. This same strain is known to infect approximately 11 percent of patients with CF who receive their care in 1 of 15 CF clinics in England and Wales," wrote Dr. Shawn D. Aaron of Ottawa Hospital Research Institute and colleagues in a news release from the journal publisher.

"Our study is the first report to suggest that common strains of P aeruginosa are shared among patients located on different continents," they added. "Our data suggest that cross-infection with P aeruginosa has occurred widely both within Ontario and between CF centers in the United Kingdom and Canada."

More information

The U.S. National Heart, Lung, and Blood Institute has more about cystic fibrosis.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, Nov. 16, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Rare, Severe Form of Morning Sickness Appears to Be Genetic
2. Severe Acne May Up Suicide Risk: Study
3. A comparison of severe outcomes during the waves of pandemic (H1N1) 2009
4. Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide
5. Discovery shows promise against severe side effects
6. Severely injured should go directly to trauma center: Research
7. Johns Hopkins researchers turn off severe food allergies in mice
8. New treatment for severe aortic stenosis shown to save lives, Stanford researchers say
9. Disc Battery Ingestion May Cause Severe Injuries in Babies
10. Gene Rx May Fight Severe Blood Disorder
11. College Campuses See Rise in Cases of Severe Mental Illness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Severe Bacterial Strain Found in Cystic Fibrosis Patients in Canada
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... Therapy continues to prove the safety and efficacy of HBOT in treating and ... across the US, points to research showing the similarities of the wounds to ...
(Date:8/23/2017)... TX (PRWEB) , ... August 23, 2017 , ... ... in the healthcare industry, made the 2017 Inc. 5000 with a three-year ... of the nation’s fastest-growing private companies and comprises the most comprehensive look at ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, ... named to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private ... of 139 percent, marking the twelfth year that the company has been included ...
(Date:8/23/2017)... ... 23, 2017 , ... A new literature review ... points out that therapeutic modalities (physical therapy) is an important part of the ... a wider scope of physical therapy options is showing promising results and supports ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
Breaking Medicine Technology: